Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/11/059608
CTRI/2023/11/059608
Not yet recruiting
Phase 2

Pharmaco-therapeutic Evaluation of Balya Action of Madhuka Pushpa on Sportspersons and Healthy Volunteers

Ayurvedic and Unani Tibbia College0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Ayurvedic and Unani Tibbia College
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Physically and mentally healthy sportspersons and healthy volunteers who fit in the Par\-Q Test (Physical Activity Readiness Questionnaire)
  • •Healthy sportspersons and healthy volunteers irrespective of sex, religion, education, occupation etc and aged between 18 or 30 years will be selected for the study.
  • •Sportspersons involved in outdoor games only, specifically athletics or swimming.

Exclusion Criteria

  • •The sportspersons and healthy volunteers who are taking treatment for any major disorders or with physical disability.
  • •Subjects on systemic or oral steroids or with alcohol or drug dependency.
  • •Subjects who have participated in any clinical trial in past 6 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
Assessing the effect of Bala and Chitrak root in the management of Pandu roga(iron deficiency anaemia)
CTRI/2024/06/068871Post Graduate Institute Of Ayurveda
Not yet recruiting
Phase 2
An Ayurvedic Management of Tension HeadacheHealth Condition 1: G442- Tension-type headache
CTRI/2023/01/049002AKASH PARASHAR
Not yet recruiting
Phase 4
Treatment of Melasma (Brownish Hyperpigmentation) through ayurvedic line of managemnet
CTRI/2022/07/044493Department Of Panchakarma
Completed
Phase 1
Efficacy and safety of Chinese herbal medicine (RCM-102) for treatment of seasonal allergic rhinitis (hayfever)seasonal allergic rhinitisInflammatory and Immune System - AllergiesRespiratory - Other respiratory disorders / diseasesAlternative and Complementary Medicine - Herbal remedies
ACTRN12612000209897Professor Charlie Xua104
Not yet recruiting
Phase 2
Therapeutic evaluation and efficacy of Regimenal modality (Dry Cupping)and Unani formulation (Asbi drug) in the management of Diabetic peripheral NeuropathyHealth Condition 1: E114- Type 2 diabetes mellitus with neurological complications
CTRI/2024/04/065099Hakim Syed Ziaul Hasan Government Unani Medical College and College